212 related articles for article (PubMed ID: 29565377)
1. How human embryonic stem cells sparked a revolution.
Cyranoski D
Nature; 2018 Mar; 555(7697):428-430. PubMed ID: 29565377
[No Abstract] [Full Text] [Related]
2. How iPS cells changed the world.
Scudellari M
Nature; 2016 Jun; 534(7607):310-2. PubMed ID: 27306170
[No Abstract] [Full Text] [Related]
3. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
Lewandowski J; Kurpisz M
Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
[TBL] [Abstract][Full Text] [Related]
4. Good practice.
Nature; 2014 Jun; 510(7504):187-8. PubMed ID: 24926498
[No Abstract] [Full Text] [Related]
5. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
Lichner Z; Mac-Way F; Yousef GM
Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
[TBL] [Abstract][Full Text] [Related]
6. Trials of embryonic stem cells to launch in China.
Cyranoski D
Nature; 2017 May; 546(7656):15-16. PubMed ID: 28569831
[No Abstract] [Full Text] [Related]
7. Japan stem-cell trial stirs envy.
Reardon S; Cyranoski D
Nature; 2014 Sep; 513(7518):287-8. PubMed ID: 25230622
[No Abstract] [Full Text] [Related]
8. Stem cells: The growing pains of pluripotency.
Hayden EC
Nature; 2011 May; 473(7347):272-4. PubMed ID: 21593837
[No Abstract] [Full Text] [Related]
9. Stem Cells: Flexible friends.
Shevde N
Nature; 2012 Feb; 483(7387):S22-6. PubMed ID: 22378125
[No Abstract] [Full Text] [Related]
10. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
11. NIH stem-cell programme closes.
Reardon S
Nature; 2014 Apr; 508(7495):157. PubMed ID: 24717485
[No Abstract] [Full Text] [Related]
12. Gene and Cell Therapies: Inserm at the Heart of Biomedical Revolutions.
Lévy Y
Hum Gene Ther; 2016 Feb; 27(2):98-9. PubMed ID: 26886831
[No Abstract] [Full Text] [Related]
13. Organoids: Avatars for Personalized Medicine.
Clevers HC
Keio J Med; 2019; 68(4):95. PubMed ID: 31875622
[TBL] [Abstract][Full Text] [Related]
14. Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies.
Kimbrel EA; Lanza R
Regen Med; 2015; 10(2):99-102. PubMed ID: 25835474
[No Abstract] [Full Text] [Related]
15. Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells.
Gao X; Yourick JJ; Sprando RL
Stem Cell Res; 2017 Dec; 25():202-212. PubMed ID: 29156376
[TBL] [Abstract][Full Text] [Related]
16. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming Enhancers in Somatic Cell Nuclear Transfer, iPSC Technology, and Direct Conversion.
Kwon D; Ji M; Lee S; Seo KW; Kang KS
Stem Cell Rev Rep; 2017 Feb; 13(1):24-34. PubMed ID: 27817181
[TBL] [Abstract][Full Text] [Related]
18. Retinal Organoids from Pluripotent Stem Cells Efficiently Recapitulate Retinogenesis.
Völkner M; Zschätzsch M; Rostovskaya M; Overall RW; Busskamp V; Anastassiadis K; Karl MO
Stem Cell Reports; 2016 Apr; 6(4):525-538. PubMed ID: 27050948
[TBL] [Abstract][Full Text] [Related]
19. An eye to the future: Researchers debate best path for stem cell-derived therapies.
Chakradhar S
Nat Med; 2016 Feb; 22(2):116-9. PubMed ID: 26845400
[No Abstract] [Full Text] [Related]
20. Phosphoinositide 3 Kinase Signaling in Human Stem Cells from Reprogramming to Differentiation: A Tale in Cytoplasmic and Nuclear Compartments.
Ramazzotti G; Ratti S; Fiume R; Follo MY; Billi AM; Rusciano I; Owusu Obeng E; Manzoli L; Cocco L; Faenza I
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
